- Category
- Articles
- Date
- July 24, 2017
- Title
-
BPCIA Questions Continue to Arise for Biosimilar Applicants
Intellectual Property special counsel Christine Willgoos co-authored the article “BPCIA Questions Continue To Arise For Biosimilar Applicants," which appeared in Law360 on July 24, 2017. The article examines the Supreme Court’s decision in Sandoz Inc. v. Amgen Inc., the first case under the Biologics Price Competition and Innovation Act of 2009.
Read the full article here.
Related People
-
-
Christine Willgoos
-
- Special Counsel
- Co-author
- New York
- vcard
-
